Roots Analysis

AUGUST 28, 2022

As a result, industry and non-industry stakeholders, are on the lookout for advanced platforms that can simultaneously capture the arrangement of multiple biomolecules (DNA, RNA, proteins and others) with single-cell or subcellular resolution. Likely Growth of the Spatial Omics Solutions Market. Our Social Media Platform.

Genome 52

Genome Genomics RNA Genome Project 52

The Pharma Data

JANUARY 31, 2021

NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina. 1, 2021 00:00 UTC.

Genome 52

Genome Genomics Life Science DNA 52

pharmaphorum

JUNE 1, 2021

The widespread use of pill presses by criminal gangs means that they can change production and ingredients rapidly to satisfy market demand. Two different types of microtaggants are now available, one produced from non-biologic DNA and the other from silica: DNA microtaggants. Silica microtaggants.

Medicine 52

Medicine DNA Pharmacy Production 52

The Pharma Data

JULY 11, 2021

TAKHZYRO is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology. Depending on regional marketing authorization, TAKHZYRO is available as a 300 mg dose in a vial or pre-filled syringe. TAKHZYRO is a fully human monoclonal antibody that specifically binds and decreases plasma kallikrein activity.

Allergies 52

Allergies Antibody Recombinant DNA Technology Production 52

Pharmaceutical Technology

FEBRUARY 3, 2023

Cell culture challenges The viral vectors used in the gene therapies currently on the market are produced in adherent human embryonic HEK-293 cell culture. The established method for this process is a triple transfection using three different DNA plasmids. For example, researchers have developed a two-plasmid cotransfection system.

Genome 244

Genome Genomics Medicine Gene Therapy 244

Roots Analysis

OCTOBER 16, 2023

DNA cloning refers to the process of generating multiple copies of a particular DNA segment. DNA and Gene Cloning involves the isolation of a DNA sequence of any species ( often a gene ) and its insertion into a vector to enable growth without any alteration in the original DNA sequence.

DNA 40

DNA Gene Protein In-Vitro 40

The Pharma Data

AUGUST 19, 2021

The VENTANA MMR RxDx Panel is the first companion diagnostic test to aid in identifying patients whose solid tumours are deficient in DNA mismatch repair (MMR), who may be eligible for JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD-1 immunotherapy from GSK. 4,5,6 PD-1 inhibitors can be effective in cancers with MMR deficiency.

FDA Approval 52

FDA Approval DNA Reagent Protein 52

The Pharma Data

OCTOBER 14, 2020

Under the terms of the non-exclusive agreement FASMAC acquires the right to use CRISPR/Cas9 technology and commercialize tools and reagents associated with it. The funds will be used to bring Ori’s innovative manufacturing platform to the market. ERS Genomics – Ireland’s ERS Genomics signed an agreement with FASMAC Co., Ltd of Japan.

Clinical Trials 52

Clinical Trials Clinical Trials Manufacturing In-Vivo 52

Roots Analysis

FEBRUARY 13, 2023

It transfers genetic information form to DNA to ribosomes, a specialized structure, or organelle, which decodes genetic information into a protein. In addition to this, more than 95 mRNA synthesis kits, that contain reagents for the synthesis of research grade mRNAs, are currently available in the market.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

The Pharma Data

DECEMBER 2, 2020

Results show the protocol demonstrated a 30Gb+ yield of long DNA reads raw data of an E. The FMv8 protocol introduces a needle-aspirate-based, cell-resuspension step prior to cell lysis that boosts DNA recovery. eTheRNA’s global programs will benefit from China Grand Pharma’s development, clinical and marketing input.

Drugs 52

Drugs Gene Editing Genome Genomics 52

Roots Analysis

JANUARY 27, 2025

The recent advancements in the field of protein expression, coupled with the launch of novel expression systems have emerged as the key drivers for the growing adoption of protein expression solutions in the overall pharma market. This can be done through various techniques such as PCR, DNA sequencing or gene synthesis.

Protein 40

Protein Reagent Marketing Gene 40